费城染色体-话题@MedSci

#费城染色体#

15篇内容 | 913人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1349024, encodeId=f96713490241e, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=Eur J Cancer：复发/难治性费城染色体阳性ALL患者采用博纳吐单抗治疗的长期疗效, objectType=article, longId=207387, objectId=dc5120e387fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc5120e387fe, replyNumber=0, likeNumber=36, createdTime=2021-02-22, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc5120e387fe, moduleTitle=Eur J Cancer：复发/难治性费城染色体阳性ALL患者采用博纳吐单抗治疗的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc5120e387fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349023, encodeId=888e1349023ac, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=Blood：高风险费城染色体阴性ALL成年患者要不要进行allo-HSCT？, objectType=article, longId=203575, objectId=a1f82035e5b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1f82035e5b3, replyNumber=0, likeNumber=22, createdTime=2020-11-22, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1f82035e5b3, moduleTitle=Blood：高风险费城染色体阴性ALL成年患者要不要进行allo-HSCT？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1f82035e5b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349022, encodeId=0dcd13490228f, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=NEJM：达沙替尼-博纳吐单抗治疗费城染色体阳性急性淋巴细胞白血病, objectType=article, longId=202407, objectId=564a20240ecb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=564a20240ecb, replyNumber=0, likeNumber=41, createdTime=2020-10-24, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=564a20240ecb, moduleTitle=NEJM：达沙替尼-博纳吐单抗治疗费城染色体阳性急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=564a20240ecb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349021, encodeId=745e1349021bf, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=费城染色体阴性急性髓系白血病复发后出现费城染色体1例, objectType=article, longId=195172, objectId=a7131951e24d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7131951e24d, replyNumber=0, likeNumber=42, createdTime=2020-06-04, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7131951e24d, moduleTitle=费城染色体阴性急性髓系白血病复发后出现费城染色体1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7131951e24d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349020, encodeId=69081349020ad, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=NEJM：Asciminib二线治疗费城染色体阳性白血病, objectType=article, longId=184673, objectId=05d51846e3ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05d51846e3ec, replyNumber=0, likeNumber=34, createdTime=2019-12-14, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05d51846e3ec, moduleTitle=NEJM：Asciminib二线治疗费城染色体阳性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05d51846e3ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349019, encodeId=dba913490191c, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, objectType=article, longId=160191, objectId=ae36160191ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae36160191ca, replyNumber=0, likeNumber=30, createdTime=2019-02-18, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae36160191ca, moduleTitle=病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae36160191ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349018, encodeId=8bc8134901894, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=Haematologica：病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, objectType=article, longId=160125, objectId=f00f160125bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f00f160125bf, replyNumber=0, likeNumber=26, createdTime=2019-02-17, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f00f160125bf, moduleTitle=Haematologica：病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f00f160125bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349017, encodeId=22e1134901e0d, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=Blood：如何治疗费城染色体阳性的急性淋巴细胞白血病？, objectType=article, longId=153814, objectId=5eb6153814dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eb6153814dd, replyNumber=0, likeNumber=40, createdTime=2018-11-19, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eb6153814dd, moduleTitle=Blood：如何治疗费城染色体阳性的急性淋巴细胞白血病？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eb6153814dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349016, encodeId=acc6134901681, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解, objectType=article, longId=153017, objectId=649b15301eb0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649b15301eb0, replyNumber=0, likeNumber=19, createdTime=2018-11-09, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649b15301eb0, moduleTitle=2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=649b15301eb0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349015, encodeId=cb57134901551, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=IJLH：使用定制的靶向富集系统组同时检测费城染色体阳性急性淋巴细胞白血病中ABL1突变和IKZF1缺失, objectType=article, longId=145618, objectId=188e14561831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=188e14561831, replyNumber=0, likeNumber=40, createdTime=2018-08-02, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=188e14561831, moduleTitle=IJLH：使用定制的靶向富集系统组同时检测费城染色体阳性急性淋巴细胞白血病中ABL1突变和IKZF1缺失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=188e14561831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349014, encodeId=8a12134901458, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=Blood：帕纳替尼（Ponatinib）用于慢性髓系白血病和费城染色体阳性白血病患者，可获得持久缓解, objectType=article, longId=133362, objectId=b4771333624d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4771333624d, replyNumber=0, likeNumber=27, createdTime=2018-03-26, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4771333624d, moduleTitle=Blood：帕纳替尼（Ponatinib）用于慢性髓系白血病和费城染色体阳性白血病患者，可获得持久缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4771333624d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349013, encodeId=2ac4134901371, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=Blood：基因组CDKN2A/2B缺失，使费城染色体阳性的ALL患者预后更差，即使采用aSCT治疗。, objectType=article, longId=127360, objectId=5f7e12e36045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f7e12e36045, replyNumber=0, likeNumber=31, createdTime=2018-01-24, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f7e12e36045, moduleTitle=Blood：基因组CDKN2A/2B缺失，使费城染色体阳性的ALL患者预后更差，即使采用aSCT治疗。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f7e12e36045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349012, encodeId=73e113490122e, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=成年费城染色体阳性急性淋巴细胞白血病患者的疾病流行率与治疗效果调研, objectType=article, longId=83264, objectId=96fb832645e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96fb832645e, replyNumber=0, likeNumber=18, createdTime=2016-11-30, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96fb832645e, moduleTitle=成年费城染色体阳性急性淋巴细胞白血病患者的疾病流行率与治疗效果调研, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96fb832645e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349011, encodeId=439a1349011ad, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=BiTE免疫疗法Blincyto治疗费城染色体阴性白血病III期临床成功, objectType=article, longId=63534, objectId=bde06353427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bde06353427, replyNumber=0, likeNumber=30, createdTime=2016-02-21, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bde06353427, moduleTitle=BiTE免疫疗法Blincyto治疗费城染色体阴性白血病III期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bde06353427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349010, encodeId=da3e13490107e, content=<a href='/topic/show?id=d5fd925019c' target=_blank style='color:#2F92EE;'>#费城染色体#</a>, objectTitle=NEJM:Ponatinib可有效治疗费城染色体阳性白血病, objectType=article, longId=26672, objectId=a603266e293, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a603266e293, replyNumber=0, likeNumber=33, createdTime=2013-11-20, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a603266e293, moduleTitle=NEJM:Ponatinib可有效治疗费城染色体阳性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a603266e293)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

费城染色体

2020-05-29

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

Eur J Cancer：复发/难治性费城染色体阳性ALL患者采用博纳吐单抗治疗的长期疗效

2021-02-22

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

Blood：高风险费城染色体阴性ALL成年患者要不要进行allo-HSCT？

2020-11-22

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

NEJM：达沙替尼-博纳吐单抗治疗费城染色体阳性急性淋巴细胞白血病

2020-10-24

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

费城染色体阴性急性髓系白血病复发后出现费城染色体1例

2020-06-04

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

NEJM：Asciminib二线治疗费城染色体阳性白血病

2019-12-14

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1

2019-02-18

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

Haematologica：病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1

2019-02-17

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

Blood：如何治疗费城染色体阳性的急性淋巴细胞白血病？

2018-11-19

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解

2018-11-09

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

IJLH：使用定制的靶向富集系统组同时检测费城染色体阳性急性淋巴细胞白血病中ABL1突变和IKZF1缺失

2018-08-02

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

Blood：帕纳替尼（Ponatinib）用于慢性髓系白血病和费城染色体阳性白血病患者，可获得持久缓解

2018-03-26

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

Blood：基因组CDKN2A/2B缺失，使费城染色体阳性的ALL患者预后更差，即使采用aSCT治疗。

2018-01-24

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

成年费城染色体阳性急性淋巴细胞白血病患者的疾病流行率与治疗效果调研

2016-11-30

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

BiTE免疫疗法Blincyto治疗费城染色体阴性白血病III期临床成功

2016-02-21

ymljack (审核中...)

前往app查看评论内容

#费城染色体#

NEJM:Ponatinib可有效治疗费城染色体阳性白血病

2013-11-20

科室
- - 订阅+
  - 更多科室
工具
服务